Show HN: We created the most comprehensive global sales tax/VAT/GST index
The text provides a comprehensive guide on VAT and sales tax rates worldwide, detailing rates, B2B reverse charge, thresholds, and digital tax status. It aids businesses in complying with tax regulations efficiently.
Read original articleThe provided text contains a detailed list of VAT and sales tax rates for various jurisdictions around the world, including Europe, the United States, Canada, and Asia-Pacific countries. The information includes tax rates, B2B reverse charge availability, registration thresholds, and whether digital products are taxable. Each entry specifies the region, tax rate, B2B reverse charge status, registration threshold, and whether digital products are taxable. The data is structured to help businesses ensure compliance with VAT and sales tax regulations in different countries. The guide is interactive and allows users to assess their compliance easily. It also mentions that the information is provided by loofa, a tool that facilitates routing between Paddle and Stripe based on tax requirements.
Related
European Union regulators accuse Apple of breaching the bloc's tech rules
EU accuses Apple of Digital Markets Act violations for restricting App Store alternatives and charging high developer fees. New probe initiated on contractual terms. Apple defends changes, faces potential fines up to 10%.
Pharma firms stash profits in Europe's tax havens
Pharma firms hide €580 billion in European tax havens, affecting drug prices and patient access. Companies exploit tax loopholes, impacting healthcare funding. Calls for transparency and accountability in the pharmaceutical industry arise.
Related
European Union regulators accuse Apple of breaching the bloc's tech rules
EU accuses Apple of Digital Markets Act violations for restricting App Store alternatives and charging high developer fees. New probe initiated on contractual terms. Apple defends changes, faces potential fines up to 10%.
Pharma firms stash profits in Europe's tax havens
Pharma firms hide €580 billion in European tax havens, affecting drug prices and patient access. Companies exploit tax loopholes, impacting healthcare funding. Calls for transparency and accountability in the pharmaceutical industry arise.